Cipla, Aurobindo, Torrent are 3 picks of HSBC on healthy Q4 expectations

The strong growth in the US markets led by large product launches has helped drive earnings…

Sagar Doshi of Nuvama recommends buying these three stocks tomorrow

Stock Market News: The Indian stock market benchmark indices, Sensex and Nifty 50, began the financial…

Pharma Outlook 2024: How are Cipla, Sun Pharma, others likely to perform?

All these factors have recently contributed to the strong earnings of domestic pharma companies.  As we…

Stocks to Watch: SBI, Bata India, PB Fintech, ZEE, Sun Pharma, Lupin, and Others – News18

Last Updated: December 18, 2023, 08:55 IST Stocks To Watch on December 18: GIFT Nifty on the…

Sun Pharma, Lupin recall drugs in US over manufacturing issues: USFDA

Leading drugmakers Sun Pharma and Lupin have recalled their products in the US market over manufacturing…

ICICI Bank, SBI, Maruti, Lupin among top 16 picks by Axis Securities

ICICI Bank, Maruti Suzuki India, State Bank of India, Lupin ltd, Federal Bank, Varun Beverages, TVS…

Lupin’s Mandideep facility receives EIR from USFDA

Drug maker, Lupin, received an Establishment Inspection Report (EIR) from the US Food and Drug Administration…

Nifty Pharma gains driven on robust growth environment; Cipla, Sun top picks

Indian stock market: On a day when benchmark indices were down half a percent Nifty Pharma…

Lupin, Federal Bank, Ashok Leyland among top midcap stocks to buy

Following the robust rally, the outlook for good quality midcap stocks still remains bullish, analysts said.…

Lupin share price hits 52-week high, up about 65% in a year; should you buy?

Lupin share price rose over 4 per cent to hit its fresh 52-week high of ₹1,078…